Hickok, J T <br/><br/>
Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.  [electronic resource] 

 -  Cancer  Jul 1999 
 - 64-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(19990701)86:1<64::aid-cncr11>3.0.co;2-#  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiemetics--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Breast Neoplasms, Male--drug therapy<br/>Carcinoma--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Serotonin Antagonists--administration & dosage<br/>Treatment Outcome<br/>Vomiting, Anticipatory--chemically induced